Recent patents and advances in Hepatocyte-like cells differentiation by perinatal stem cells

Rita Anzalone, Melania Lo Iacono, Simona Corrao, Tiziana Gorgun, Felicia Farina, Giampiero La Rocca

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Chronic liver diseases constitute one of the main causes of death in western countries. Orthotopic liver transplantation still remains the final therapeutic approach to these diseases, but alternative therapeutic strategies are actively researched. Hepatocyte transplantation is considered a promising approach, even if this technique presents many limitations. These factors boosted the research for alternative cell sources to derive functional hepatocytes. In the last years, research on basic biology and differentiative ability of adult, embryonic and perinatal stem cells has constantly increased. The term "perinatal" indicates stem cell populations derived from foetal sources such as placental chorionic villi, chorion, amnion, amniotic fluid and umbilical cord. These cellular populations may differentiate towards several mature cell types, derived from all three germ layers. Multiple reports suggested that such cells can be differentiated towards hepatoblasts and hepatocyte-like cells, heralding their possible use for the treatment of inflammation, trauma and degeneration in liver disorders. In this review, we analyze the patents which were developed concerning hepatic differentiation ability of perinatal stem cells and their possible role in regenerative medicine.

Original languageEnglish (US)
Pages (from-to)227-236
Number of pages10
JournalRecent Patents on Regenerative Medicine
Volume3
Issue number3
DOIs
StatePublished - Nov 27 2013
Externally publishedYes

Fingerprint

Patents
Cell Differentiation
Hepatocytes
Stem Cells
Chorionic Villi
Chorion
Germ Layers
Amnion
Regenerative Medicine
Umbilical Cord
Liver
Amniotic Fluid
Embryonic Stem Cells
Research
Liver Transplantation
Population
Liver Diseases
Cause of Death
Chronic Disease
Therapeutics

Keywords

  • Amnion
  • Amniotic fluid
  • Cellular therapy
  • Hepatocyte differentiation patents
  • Immune modulation
  • Liver diseases
  • Liver regeneration
  • Mesenchymal stem cells
  • Placental stem cells
  • Wharton's jelly

ASJC Scopus subject areas

  • Developmental Neuroscience
  • Cell Biology
  • Developmental Biology

Cite this

Recent patents and advances in Hepatocyte-like cells differentiation by perinatal stem cells. / Anzalone, Rita; Lo Iacono, Melania; Corrao, Simona; Gorgun, Tiziana; Farina, Felicia; La Rocca, Giampiero.

In: Recent Patents on Regenerative Medicine, Vol. 3, No. 3, 27.11.2013, p. 227-236.

Research output: Contribution to journalReview article

Anzalone, Rita ; Lo Iacono, Melania ; Corrao, Simona ; Gorgun, Tiziana ; Farina, Felicia ; La Rocca, Giampiero. / Recent patents and advances in Hepatocyte-like cells differentiation by perinatal stem cells. In: Recent Patents on Regenerative Medicine. 2013 ; Vol. 3, No. 3. pp. 227-236.
@article{fcfb43dc636c4ccc977b2e88155eec62,
title = "Recent patents and advances in Hepatocyte-like cells differentiation by perinatal stem cells",
abstract = "Chronic liver diseases constitute one of the main causes of death in western countries. Orthotopic liver transplantation still remains the final therapeutic approach to these diseases, but alternative therapeutic strategies are actively researched. Hepatocyte transplantation is considered a promising approach, even if this technique presents many limitations. These factors boosted the research for alternative cell sources to derive functional hepatocytes. In the last years, research on basic biology and differentiative ability of adult, embryonic and perinatal stem cells has constantly increased. The term {"}perinatal{"} indicates stem cell populations derived from foetal sources such as placental chorionic villi, chorion, amnion, amniotic fluid and umbilical cord. These cellular populations may differentiate towards several mature cell types, derived from all three germ layers. Multiple reports suggested that such cells can be differentiated towards hepatoblasts and hepatocyte-like cells, heralding their possible use for the treatment of inflammation, trauma and degeneration in liver disorders. In this review, we analyze the patents which were developed concerning hepatic differentiation ability of perinatal stem cells and their possible role in regenerative medicine.",
keywords = "Amnion, Amniotic fluid, Cellular therapy, Hepatocyte differentiation patents, Immune modulation, Liver diseases, Liver regeneration, Mesenchymal stem cells, Placental stem cells, Wharton's jelly",
author = "Rita Anzalone and {Lo Iacono}, Melania and Simona Corrao and Tiziana Gorgun and Felicia Farina and {La Rocca}, Giampiero",
year = "2013",
month = "11",
day = "27",
doi = "10.2174/22102965113039990022",
language = "English (US)",
volume = "3",
pages = "227--236",
journal = "Current Regenerative Medicine",
issn = "2468-4244",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - Recent patents and advances in Hepatocyte-like cells differentiation by perinatal stem cells

AU - Anzalone, Rita

AU - Lo Iacono, Melania

AU - Corrao, Simona

AU - Gorgun, Tiziana

AU - Farina, Felicia

AU - La Rocca, Giampiero

PY - 2013/11/27

Y1 - 2013/11/27

N2 - Chronic liver diseases constitute one of the main causes of death in western countries. Orthotopic liver transplantation still remains the final therapeutic approach to these diseases, but alternative therapeutic strategies are actively researched. Hepatocyte transplantation is considered a promising approach, even if this technique presents many limitations. These factors boosted the research for alternative cell sources to derive functional hepatocytes. In the last years, research on basic biology and differentiative ability of adult, embryonic and perinatal stem cells has constantly increased. The term "perinatal" indicates stem cell populations derived from foetal sources such as placental chorionic villi, chorion, amnion, amniotic fluid and umbilical cord. These cellular populations may differentiate towards several mature cell types, derived from all three germ layers. Multiple reports suggested that such cells can be differentiated towards hepatoblasts and hepatocyte-like cells, heralding their possible use for the treatment of inflammation, trauma and degeneration in liver disorders. In this review, we analyze the patents which were developed concerning hepatic differentiation ability of perinatal stem cells and their possible role in regenerative medicine.

AB - Chronic liver diseases constitute one of the main causes of death in western countries. Orthotopic liver transplantation still remains the final therapeutic approach to these diseases, but alternative therapeutic strategies are actively researched. Hepatocyte transplantation is considered a promising approach, even if this technique presents many limitations. These factors boosted the research for alternative cell sources to derive functional hepatocytes. In the last years, research on basic biology and differentiative ability of adult, embryonic and perinatal stem cells has constantly increased. The term "perinatal" indicates stem cell populations derived from foetal sources such as placental chorionic villi, chorion, amnion, amniotic fluid and umbilical cord. These cellular populations may differentiate towards several mature cell types, derived from all three germ layers. Multiple reports suggested that such cells can be differentiated towards hepatoblasts and hepatocyte-like cells, heralding their possible use for the treatment of inflammation, trauma and degeneration in liver disorders. In this review, we analyze the patents which were developed concerning hepatic differentiation ability of perinatal stem cells and their possible role in regenerative medicine.

KW - Amnion

KW - Amniotic fluid

KW - Cellular therapy

KW - Hepatocyte differentiation patents

KW - Immune modulation

KW - Liver diseases

KW - Liver regeneration

KW - Mesenchymal stem cells

KW - Placental stem cells

KW - Wharton's jelly

UR - http://www.scopus.com/inward/record.url?scp=84888033476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888033476&partnerID=8YFLogxK

U2 - 10.2174/22102965113039990022

DO - 10.2174/22102965113039990022

M3 - Review article

AN - SCOPUS:84888033476

VL - 3

SP - 227

EP - 236

JO - Current Regenerative Medicine

JF - Current Regenerative Medicine

SN - 2468-4244

IS - 3

ER -